We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Richard Bonneau - Executive Director, Prescient Design, Biomolecular design, ML

Richard Bonneau

Executive Director, Prescient Design, Biomolecular design, ML

Postdoc Mentor
"We are making models that combine strengths from both machine learning and molecular structure worlds, and hope that these models can power new generations of lab-in-the-loop drug discovery pipelines."
1
Awards & Honors

I combine biophysics and computational methods to build new approaches to biomolecular design. I have a background in computational structural biology. As a postdoc I became more involved in genomics data analysis and this led to a deep specialisation in the inference and modeling of biological networks. My group now combines machine learning approaches with physical models of key biological processes to make progress on molecular and biomolecular design.

Postdoctoral Mentor

The Postdoc program at Genentech has always been a foundry for innovation in biotech, and I feel quite lucky to be able to participate. Postdoctoral Fellows at Prescient will help us push boundaries in ML, f unify approaches, and generally think big. The postdoc program at Genentech helps comprise our ‘basic science’ core and will also interface with our Frontiers group and other ML focused efforts across the Roche family.